L. Fedele et al., DANAZOL VERSUS A GONADOTROPIN-RELEASING-HORMONE AGONIST AS PREOPERATIVE PREPARATION FOR HYSTEROSCOPIC METROPLASTY, Fertility and sterility, 65(1), 1996, pp. 186-188
Objective: To compare the efficacy of danazol and a GnRH agonist as pr
eoperative preparation for hysteroscopic metroplasty in women with sep
tate uterus. Design: Prospective randomized clinical study. Setting: T
ertiary care center. Patients: Thirty patients with septate uterus. In
terventions: The patients were randomized to treatment with danazol 60
0 mg/d for 2 to 4 weeks (n = 15) or with leuprolide acetate depot 3.75
mg for 2 months (n = 15) as preoperative therapy for hysteroscopic me
troplasty. Main Outcome Measures: At the intervention the hysteroscopi
st evaluated difficulty in dilation of the cervical canal, presence of
endometrial fragments, bleeding, difficulty in maneuvering the resect
oscope, and operating time. Results: Both the treatments were well tol
erated. Metroplasty was simpler overall in the danazol group and also
faster in introducing the resectoscope through the cervical canal and
maneuvering it in the uterine cavity were both easier. Bleeding was mo
dest in both groups and the anatomic outcome of the operation was simi
lar. Conclusion: Short preoperative preparation with danazol results i
n favorable operating conditions at limited costs with minimal side ef
fects.